Navigation Links
Risks involved with transgenic fish
Date:8/31/2009

Fast growing transgenic fish can revolutionise commercial fish farming and relieve the pressure on overexploited fish stocks. But what happens in the natural environment if transgenic fish escape? Researchers at the University of Gothenburg have studied transgenic fish on behalf of the EU and are urging caution: -Until further notice transgenic fish should be bred in closed systems on land, says Fredrik Sundstrm at the Department of Zoology, University of Gothenburg.

By furnishing fish with genes from other organisms, so-called transgenes, researchers have succeeded in producing fish that grow considerably faster or are more resistant to diseases. Fish can also be modified to cope better with cold, which facilitates breeding in colder conditions. There are major benefits for commercial fish farming as transgenic fish are expected to deliver higher production and better yields. However, transgenic fish can also entail risks and undesirable effects on the natural environment.

More resistant to toxins

For example, transgenic fish can be more resistant to environmental toxins, which could entail the accumulation of toxins that ultimately end up in consumers. There are also misgivings that the higher level of growth hormone in the fish can affect people. Researchers at the University of Gothenburg have therefore been commissioned by the EU to study the environmental effects of GMO (genetically modified organisms) within fish farming. The results of the studies show that the genetically modified fish should be treated with great care.

Fredrik Sundstrm, PhD at the Department of Zoology, has studied transgenic salmon and rainbow trout to ascertain what ecological risks they might constitute for the natural environment. The study, which simulated escapes in a laboratory environment, shows that transgenic fish have a considerably greater effect on the natural environment than hatchery-reared non-transgenic fish when they escape. For example, genetically modified fish survive better when there is a shortage of food, and benefit more than non-transgenic fish from increasing water temperatures.

It is probably due to the fact that genetically modified fish have a greater ability to compete and are better at converting food, says Fredrik Sundstrm.

Natural breeds are under threat

If transgenic fish become established in natural stocks they would be able to outcompete the natural breeds. However, conducting studies in a laboratory environment that imitates nature is complicated, which makes it difficult to predict how escaped transgenic fish affect the natural environment. Fredrik Sundstrm's conclusion is that international consensus is required before commercial farming can be permitted, and that a precautionary principle must be applied.

One option is to farm the transgenic fish on land, which would make escape impossible. At least fertile fish should be kept in a closed system, says Fredrik Sundstrm. As of yet no country has permitted commercial farming of transgenic fish, but several applications for such operations are under consideration by authorities in both the USA and the EU.


'/>"/>

Contact: Fredrik Sundstrom
fred.sundstrom@gmail.com
46-073-408-4922
University of Gothenburg
Source:Eurekalert  

Related biology news :

1. Preimplantation genetic diagnosis may pose neurological risks
2. Climate change: Global risks, challenges and decisions
3. Newly described contaminant sources in Katrina-flooded homes pose health risks
4. Rice eyes risks of quantum dots
5. New insights into a leading poultry disease and its risks to human health
6. Athletes not spared from health risks of metabolic syndrome
7. More freedom to take risks: DFG funds the first Reinhart Koselleck Projects
8. Vitamin D deficiency in infants and nursing mothers carries long-term disease risks
9. USC researchers head global effort to study genetic risks that contribute to psychiatric diseases
10. 6 environmental research studies reveal critical health risks from plastic
11. African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Risks involved with transgenic fish
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/2/2017)... , Feb. 2, 2017  EyeLock LLC, a market ... new white paper " What You Should Know About ... of ensuring user authenticity is a growing concern. In ... of users. However, traditional authentication schemes such as username/password ... Biometric authentication offers an elegant solution to the ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... 2017  Seattle,s upscale Capitol Hill neighborhood, with its swanky shops, ... a head lice treatment salon to set up shop. But ... and a French bistro on E Madison Ave, and CEO ... any old lice clinic, we pride ourselves on being a ... some of the stigma associated with lice. Everyone can get ...
(Date:2/23/2017)... ... February 23, 2017 , ... David Nolte, PhD ... Reception at Purdue Research Park of West Lafayette, Indiana. , The ... outstanding contributions to, and success with, commercializing discoveries from Purdue research. “This award ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... research tools, announced the acquisition of GenWay Biotech ... a comprehensive service and product offering for both ... acquisition will facilitate growth and enhance capabilities for ... antibodies, and ELISA assays will nicely complement ASB,s ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... has acquired Kendall Research Systems, LLC (KRS) clinical development program. KRS ... neural interface technology for research and clinical applications. The terms of the transaction ...
Breaking Biology Technology: